Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease

5 Feb 2010

Abstract excerpt

BACKGROUND: Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects about five million people worldwide. Diagnosis remains clinical, based on phenotypic patterns. The discovery of laboratory markers that will enhance diagnostic accuracy, allow pre-clinical detection and tracking of disease progression is critically needed. These biomarkers may include transcripts with different isoforms....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parkinson's Disease Mechanisms and Treatments
Share to RNA regulation and disease
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20161708
DOI: 10.1371/journal.pone.0009104

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's DiseasePMID 20161708Read ↗

Aberrant Alternative Splicing Events in Parkinson's DiseaseSemantic proximity Read ↗

Plasma acellular transcriptome contains Parkinson’s disease signatures that can inform clinical diagnosisSemantic proximity Read ↗

Exon Arrays Reveal Alternative Splicing Aberrations in Parkinson’s Disease LeukocytesSemantic proximity Read ↗

Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls.Semantic proximity Read ↗

Integrative analysis of plasma and substantia nigra in Parkinson’s disease: unraveling biomarkers and insights from the lncRNA–miRNA–mRNA ceRNA networkSemantic proximity Read ↗

Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomesSemantic proximity Read ↗

Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease.Semantic proximity Read ↗

Blood transcriptomics reveals a Parkinson’s disease signature and heterogeneous prodromal molecular profiles in isolated RBDSemantic proximity Read ↗

Parkinson’s disease is associated with an imbalance in circular RNA expressionSemantic proximity Read ↗

SNCA locus Triplication Drives Severe Parkinson’s Disease: Platelet and Blood Expression Profiles Evidence Systemic InvolvementSemantic proximity Read ↗

miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s diseaseSemantic proximity Read ↗

The Exon-Based Transcriptomic Analysis of Parkinson’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.